Abiopharma

🔍 Machiels Alec (Director)

Company: Apellis Pharmaceuticals, Inc. (APLS)

Report Date: 2026-01-01

Detailed Transactions and Holdings:

• Acquired 7,961 shares of Common Stock (Direct)
  Date: 2026-01-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 384,989.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-01 | Code: H | nature_of_ownership: Indirect Owner (Bauhaus 1 LLC) | shares_owned_after: 250,000.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-01 | Code: H | nature_of_ownership: Indirect Owner (Owned by Spouse) | shares_owned_after: 11,950.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-01 | Code: H | nature_of_ownership: Indirect Owner (Spouse Trust) | shares_owned_after: 150,000.00 | Footnotes: F4
• Acquired 14,684 shares of Stock Option (Right to Buy) at $25.12 per share (Derivative)
  Date: 2026-01-01 | Code: A | Expires: 2033-12-31 | equity_swap_involved: 0 | shares_owned_after: 14,684.00 | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: This restricted stock unit was granted on January 1, 2026. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as a director at his election.
• F2: The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.
• F3: Owned by spouse.
• F4: On September 7, 2021, the reporting person's spouse transferred 150,000 shares of Apellis Pharmaceuticals, Inc. common stock to her trust, of which the reporting person is the trustee.
• F5: This option was granted on January 1, 2026. The option vests quarterly on the last day of each quarter from the date of grant, subject to his continued service as a director and expires seven years after the date of grant.